An Improved Harvest and in Vitro Expansion Protocol for Murine Bone Marrow-Derived Mesenchymal Stem CellsSONG XU; DE BECKER, Ann; VAN CAMP, Ben et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 105940.1-105940.10, 4Article

Multiple myeloma biology: lessons from the 5TMM modelsVANDERKERKEN, Karin; ASOSINGH, Kewal; CROUCHER, Peter et al.Immunological reviews. 2003, Vol 194, pp 196-206, issn 0105-2896, 11 p.Article

The role of the insulin-like growth factor 1 receptor axis in multiple myelomaMENU, Eline; VAN VALCKENBORGH, Els; VAN CAMP, Ben et al.Archives of physiology and biochemistry. 2009, Vol 115, Num 2, pp 49-57, issn 1381-3455, 9 p.Conference Paper

The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor PicropodophyllinLEMAIRE, Miguel; FRISTEDT, Charlotte; VAN CAMP, Ben et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2230-2239, issn 1078-0432, 10 p.Article

Inhibition of p38α mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myelomaVANDERKERKEN, Karin; MEDICHERLA, Satya; CROUCHER, Peter I et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4572-4577, issn 0008-5472, 6 p.Article

The involvement of stromal derived factor 1α in homing and progression of multiple myeloma in the 5TMM modelMENU, Eline; ASOSINGH, Kewal; VANDERKERKEN, Karin et al.Haematologica (Roma). 2006, Vol 91, Num 5, pp 605-612, issn 0390-6078, 8 p.Article

Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells : the association with disease activity and survivalVAN DE BROEK, Isabelle; LELEU, Xavier; SCHOTS, Rik et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 200-206, issn 0390-6078, 7 p.Article

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myelomaVANDERKERKEN, Karin; DE LEENHEER, Evy; SHIPMAN, Claire et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 287-289, issn 0008-5472, 3 p.Article

Bisphosphonates: Mechanisms of action in multiple myelomaSHIPMAN, Claire M; ROGERS, Michael J; VANDERKERKEN, Karin et al.Acta oncologica (Stockholm). 2000, Vol 39, Num 7, pp 829-835, issn 0284-186XConference Paper

Apomine™, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoEDWARDS, Claire M; MUELLER, Gabrielle; VANDERKERKEN, Karin et al.International journal of cancer. 2007, Vol 120, Num 8, pp 1657-1663, issn 0020-7136, 7 p.Article

Multifunctional role of matrix metalloproteinases in multiple myeloma: A study in the 5T2MM mouse modelVAN VALCKENBORGH, Els; CROUCHER, Peter I; VAN RIET, Ivan et al.The American journal of pathology. 2004, Vol 165, Num 3, pp 869-878, issn 0002-9440, 10 p.Article

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survivalCROUCHER, Peter I; DE RAEVE, Hendrik; PERRY, Mark J et al.Journal of bone and mineral research (Print). 2003, Vol 18, Num 3, pp 482-492, issn 0884-0431, 11 p.Article

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myelomaCROUCHER, Peter I; SHIPMAN, Claire M; DUNSTAN, Colin R et al.Blood. 2001, Vol 98, Num 13, pp 3534-3540, issn 0006-4971Article

Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myelomaCAERS, Jo; HOSE, Dirk; JANBOS, Tomas et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 163-167, issn 0390-6078, 5 p.Article

Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of MyelomaDELEU, Sarah; LEMAIRE, Miguel; VANDERKERKEN, Karin et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5307-5311, issn 0008-5472, 5 p.Article

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP : an in vitro and in vivo study in the 5T33MM mouse modelMENU, Eline; JERNBERG-WIKLUND, Helena; VANDERKERKEN, Kann et al.Blood. 2006, Vol 107, Num 2, pp 655-660, issn 0006-4971, 6 p.Article